Clinicopathological impacts of c-Met overexpression in epithelial ovarian cancer: a meta-analysis and systemic review

Jung Han Kim; Jung Han Kim; Hyun Joo Jang; Hyun Joo Jang; Bum Jun Kim; Bum Jun Kim; Sung Ho Park; Sung Ho Park

doi:10.18632/oncotarget.23889

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/03/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Clinicopathological impacts of c-Met overexpression in epithelial ovarian cancer: a meta-analysis and systemic review

Jung Han Kim _, Jung Han Kim, Hyun Joo Jang, Hyun Joo Jang, Bum Jun Kim, Bum Jun Kim, Sung Ho Park and Sung Ho Park _

Jung Han Kim1, Hyun Joo Jang2, Bum Jun Kim1,3 and Sung Ho Park4

1 Division of Hemato-Oncology, Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Republic of Korea

2 Department of Internal Medicine, Dongtan Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Gyeonggi-Do, Republic of Korea

3 Department of Internal Medicine, National Army Capital Hospital, The Armed Forces Medical Command, Gyeonggi-Do, Republic of Korea

4 Department of Obstetrics and Gynecology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Korea

Correspondence to:

Jung Han Kim, email: [email protected]

Sung Ho Park, email: [email protected]

Keywords: c-Met; ovarian cancer; prognosis; meta-analysis; review

Received: September 30, 2017 Accepted: November 13, 2017 Epub: January 03, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23889

Publication Alerts

Withdrawal Notice

Research Papers:

Clinicopathological impacts of c-Met overexpression in epithelial ovarian cancer: a meta-analysis and systemic review